Drug Regulatory Reform in India – 31st March, 2014
Ali Mehdi
Thursday, 7th January 2016
KG Marg, New Delhi 110003

Mr Arun Maira, Member, Planning Commission, Government of India delivering the inaugural address.
 
As a part of ICRIER’s Health Policy Initiative, full day workshop was conducted on drug regulatory reforms in India on 31st March 2014 in New Delhi. The goal of this workshop was to discuss and deliberate various issues of concern in the context of drug regulation in India, which would be taken up to develop ICRIER’s research agenda in this field. It was attended by distinguished experts from the government, international organizations, academia, industry as well as the civil society. Discussions focused on following themes: drug safety, Good Manufacturing Practices (GMP), Post-Marketing Surveillance (PMS), clinical trials and new drug approvals and other relevant issues.
 
The inaugural address was delivered by Mr Arun Maira, Member, Planning Commission, Government of India. Notable participants included Dr B R Jagashetty, Former Drug Controller of Karnataka; Mr Sudhanshu Pandey, Joint Secretary, Ministry of Commerce and Industry, Government of India; Dr A Ramkishan, Deputy Drug Controller, Ministry of Health & Family Welfare, Government of India; Mr Ratnesh Sahay, Advisor, Competition Commission of India; Dr Genevieve Begkoyian, Chief of Health, UNICEF India; Dr Shubhashis Gangopadhyay, Research Director, India Development Foundation; Dr Aditya Bhattacharjea, Professor and Head of Department, Department of Economics, Delhi School of Economics; Dr Amir Ullah Khan, President, Glocal University; Mr Richard F Kingham, Partner, Covington and Burling (Washington D.C.); Ms Susan C Winckler, President, Food and Drug Law Institute (Washington D.C.); Dr Bobby John, President, Global Health Advocates, among others.

FacebookTwitterGoogle+Share